Good decisions require good information
Find hidden gems and smart strategies from top experts when you join Seeking Alpha.
OXBDF Oxford Biomedica plcStock Price & Overview
$4.48
OXBDF Stock Price
Quant Ranking
OXBDF Analysis
OXBDF News
Latest Headlines
People Also Follow
Similar to OXBDF
ETFs Holding OXBDF
OXBDF Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.
OXBDF Revenue
OXBDF Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
Dividends
OXBDF Ownership
OXBDF Peers
Risk
Technicals
OXBDF Transcripts
Investor Presentations
OXBDF SEC Filings
OXBDF Income Statement
OXBDF Balance Sheet
OXBDF Cash Flow Statement
OXBDF Long Term Solvency
Discover More
You may be interested in: